5 Best UK Stocks to Buy According to Hedge Funds

In this article, we will list the 5 Best UK Stocks to Buy According to Hedge Funds. Please visit 12 Best UK Stocks to Buy According to Hedge Funds to Buy Now if you would like to see the extended list and the methodology behind it.

15 Most Valuable British Companies

5. Rentokil Initial plc (NYSE:RTO)

On March 16, 2026, Citi analyst Marc Van’T Sant raised the price target on Rentokil Initial plc (NYSE:RTO) to 575 GBp from 550 GBp previously and maintained a Buy rating on the shares.

On March 12, 2026, UBS analyst Nicole Manion upgraded Rentokil to Buy from Neutral and raised the price target to 540 GBp from 430 GBp, marking the first positive stance since 2020. UBS said organic volumes appear set to return to growth and costs are stabilizing, suggesting a “valuable compounder could be re-emerging.” Oppenheimer also raised its price target on Rentokil Initial plc (NYSE:RTO) to $35 from $30 and maintained an Outperform rating, noting Q4 revenue of $1.7B was in line with expectations, supported by improving North America pest control trends, with FY26 tracking in line with consensus despite weather disruptions and geopolitical uncertainty.

Earlier, Rentokil reported 2025 revenue of $6.91B, up 2.6% organically and broadly in line with the $6.92B consensus estimate, while adjusted operating profit rose 5.4% to $1.07B with margins expanding to 15.5%. The company also said Chairman Richard Solomons plans to retire once a successor is appointed.

Rentokil Initial plc (NYSE:RTO) provides pest control and related route-based services across global markets.

4. Immunocore Holdings plc (NASDAQ:IMCR)

On March 16, 2026, Jefferies downgraded Immunocore Holdings plc (NASDAQ:IMCR) to Hold from Buy previously with a price target of $33, down from $48, after assuming coverage. Jefferies has said that Immunocore Holdings plc’s (NASDAQ:IMCR) lead product Kimmtrak addresses a “moderate” total addressable market in uveal melanoma and is nearing peak sales, adding that further upside now depends on pipeline success, where “shots on goal look risky.”

Last month, Immunocore Holdings plc (NASDAQ:IMCR) reported fourth-quarter EPS of (60c), below the (20c) consensus estimate. Revenue came in at $104.5M compared with the $107.77M consensus. Chief Executive Officer Bahija Jallal has said that Immunocore Holdings plc (NASDAQ:IMCR) delivered “a productive year of growth and progress” in 2025, supported by $400M in Kimmtrak sales and continued pipeline development. Bahija Jallal has added that 2026 will focus on executing clinical trials, with key data expected in oncology and the start of its first autoimmune study.

Immunocore Holdings plc (NASDAQ:IMCR) develops and commercializes immunomodulating therapies targeting cancer, infectious diseases, and autoimmune conditions.

3. Navigator Holdings Ltd. (NYSE:NVGS)

On March 19, 2026, Navigator Holdings Ltd. (NYSE:NVGS) announced that BW Group, its selling shareholder, is offering 7M shares in a secondary public offering, with the company not issuing any shares and receiving no proceeds. Navigator said it intends to repurchase 3.5M shares from the underwriters at the public offering price, though the buyback is not contingent on the completion of the offering. Citigroup, DNB Carnegie, Fearnley Securities, and Pareto Securities are acting as joint book-running managers. The deal was later increased to 8.0M shares from 7.0M and priced below the prior closing price of $19.17.

On March 13, 2026, Deutsche Bank raised its price target on Navigator Holdings Ltd. (NYSE:NVGS) to $25 from $24 previously and maintained a Buy rating, citing a fourth-quarter earnings beat and a positive outlook.

On March 11, 2026, Navigator Holdings Ltd. (NYSE:NVGS) reported preliminary fourth-quarter revenue of $152.83M versus the $136.15M consensus estimate and said total liquidity stood at $296.3M as of year-end 2025.

Navigator Holdings Ltd. (NYSE:NVGS) owns and operates a global fleet of vessels transporting liquefied gases, including petrochemical gases, LPG, and ammonia.

2. Janus Henderson Group plc (NYSE:JHG)

On March 24, 2026, Victory Capital Holdings, Inc. said it has withdrawn its proposal to acquire Janus Henderson Group plc (NYSE:JHG), stating it would only proceed with a negotiated transaction supported by Janus Henderson’s Special Committee. The company said it remains interested in Janus Henderson as a “high-quality organization” and continues to pursue acquisitions that enhance scale, product breadth, and global distribution.

On the same day, Janus Henderson Group plc (NYSE:JHG) announced an amended agreement with Trian Fund Management and General Catalyst, raising the offer price to $52.00 per share in cash. The revised terms also allow for a $1.00 per share quarterly dividend starting July 2026 if closing is delayed due to regulatory approvals. The company said the updated offer represents a 25% premium to its unaffected share price and remains on track to close by mid-2026. Janus Henderson added that its board, following the Special Committee’s recommendation, determined Victory’s latest proposal is not actionable due to “unacceptably high closing risks,” noting multiple prior proposals had failed to address similar concerns despite extensive discussions.

Janus Henderson Group plc (NYSE:JHG) is a global asset manager serving institutional and retail clients across equity and fixed income strategies.

1. Klarna Group plc (NYSE:KLAR)

On March 19, 2026, Klarna Group plc (NYSE:KLAR) announced that its Klarna Card has reached 5M active users globally, highlighting what the company described as “rapid adoption” as consumers shift toward more flexible payment options. Chief Marketing Officer David Sandstrom said the trend reflects how users are “looking for control and flexibility in a single card,” with the ability to choose between paying immediately or over time depending on the situation.

On March 17, 2026, Klarna Group plc (NYSE:KLAR) said it surpassed 1M merchants globally, with merchant count growing 47% over the past year, including 285,000 additions in 2025 and more than 115,000 in the fourth quarter alone. Chief Commercial Officer David Sykes said reaching this milestone reflects how Klarna is becoming more embedded in everyday spending, as consumers increasingly use its services across categories ranging from home-related purchases to recurring lifestyle expenses.

Earlier in March, BofA analyst Matthew O’Neill reinstated coverage on Klarna Group plc (NYSE:KLAR) with a Buy rating and a $21 price target.

Klarna Group plc (NYSE:KLAR) operates a digital banking and payments platform offering flexible payment solutions across global markets.

While we acknowledge the potential of KLAR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KLAR and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Must-Buy Real Estate Stocks to Invest In and 11 Best High Volume Penny Stocks to Buy Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.